Home / Stocks / ALKS

ALKS insider trading

Alkermes plc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
0
Bought · 24 mo
$0
Buys · last 90 days
0 · $0
Most recent buy
—

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-08-03snyderman nancy lynn MD
Director
Sold44,472$50.35$2.2M
2026-02-02Cooke Shane
Director
Sold32,113$34.78$1.1M
2025-02-14Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Sold349,340$33.92$11.8M
2025-01-31Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Sold100,918$32.05$3.2M
2024-12-09Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Sold61,151$32.07$2.0M
2024-11-12Hopkinson Craig C.
EVP R&D, Chief Medical Officer
Sold58,996$30.08$1.8M

See ALKS on the chart

Every insider buy and sell for ALKS plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.